IMNM
Price
$11.34
Change
-$0.37 (-3.16%)
Updated
Oct 1 closing price
Capitalization
987.09M
46 days until earnings call
PRLD
Price
$1.51
Change
+$0.07 (+4.86%)
Updated
Oct 1 closing price
Capitalization
85.47M
47 days until earnings call
Interact to see
Advertisement

IMNM vs PRLD

Header iconIMNM vs PRLD Comparison
Open Charts IMNM vs PRLDBanner chart's image
Immunome
Price$11.34
Change-$0.37 (-3.16%)
Volume$1.38M
Capitalization987.09M
Prelude Therapeutics
Price$1.51
Change+$0.07 (+4.86%)
Volume$266.38K
Capitalization85.47M
IMNM vs PRLD Comparison Chart in %
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. PRLD commentary
Oct 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a StrongBuy and PRLD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 02, 2025
Stock price -- (IMNM: $11.34 vs. PRLD: $1.51)
Brand notoriety: IMNM and PRLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 117% vs. PRLD: 113%
Market capitalization -- IMNM: $987.09M vs. PRLD: $85.47M
IMNM [@Biotechnology] is valued at $987.09M. PRLD’s [@Biotechnology] market capitalization is $85.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.64B to $0. The average market capitalization across the [@Biotechnology] industry is $1.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whilePRLD’s FA Score has 1 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • PRLD’s FA Score: 1 green, 4 red.
According to our system of comparison, both IMNM and PRLD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 5 TA indicator(s) are bullish while PRLD’s TA Score has 5 bullish TA indicator(s).

  • IMNM’s TA Score: 5 bullish, 4 bearish.
  • PRLD’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both IMNM and PRLD are a good buy in the short-term.

Price Growth

IMNM (@Biotechnology) experienced а +1.25% price change this week, while PRLD (@Biotechnology) price change was +29.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.18%. For the same industry, the average monthly price growth was +12.74%, and the average quarterly price growth was +77.34%.

Reported Earning Dates

IMNM is expected to report earnings on Nov 17, 2025.

PRLD is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+4.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($987M) has a higher market cap than PRLD($85.5M). PRLD YTD gains are higher at: 18.431 vs. IMNM (10.264). PRLD has higher annual earnings (EBITDA): -133.25M vs. IMNM (-187.92M). IMNM has more cash in the bank: 268M vs. PRLD (73.2M). IMNM has less debt than PRLD: IMNM (4.14M) vs PRLD (17.9M). IMNM has higher revenues than PRLD: IMNM (12.6M) vs PRLD (7M).
IMNMPRLDIMNM / PRLD
Capitalization987M85.5M1,154%
EBITDA-187.92M-133.25M141%
Gain YTD10.26418.43156%
P/E RatioN/AN/A-
Revenue12.6M7M180%
Total Cash268M73.2M366%
Total Debt4.14M17.9M23%
TECHNICAL ANALYSIS
Technical Analysis
IMNMPRLD
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 7 days ago
88%
Declines
ODDS (%)
Bearish Trend 16 days ago
87%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBSLX53.77N/A
N/A
Neuberger Berman Quality Equity I
NQVRX61.86N/A
N/A
Nuveen Multi Cap Value I
CSRIX49.59N/A
N/A
Cohen & Steers Instl Realty Shares
SHDCX9.57N/A
N/A
American Beacon Shapiro SMID Cap Eq C
ARAGX11.28N/A
N/A
Aristotle Growth Equity A

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
+3.26%
IDYA - IMNM
59%
Loosely correlated
+0.07%
SYRE - IMNM
55%
Loosely correlated
+2.44%
RLAY - IMNM
54%
Loosely correlated
+0.58%
ARWR - IMNM
52%
Loosely correlated
+2.10%
RXRX - IMNM
52%
Loosely correlated
-0.61%
More

PRLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRLD has been loosely correlated with ATNM. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PRLD jumps, then ATNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRLD
1D Price
Change %
PRLD100%
+4.86%
ATNM - PRLD
39%
Loosely correlated
N/A
FDMT - PRLD
38%
Loosely correlated
+0.46%
IMNM - PRLD
37%
Loosely correlated
-3.16%
FULC - PRLD
37%
Loosely correlated
+1.41%
IPSC - PRLD
37%
Loosely correlated
+0.36%
More